By Iain Gilbert
Date: Thursday 06 Feb 2025
(Sharecast News) - Shares in pharmaceutical giant Bristol Myers Squibb headed south in early trading as its solid Q4 revenue performance was offset by FY25 guidance that fell short of Wall Street expectations.
Currency | US Dollars |
Share Price | $ 45.45 |
Closing Price Change | $ -0.28 |
% Change | 0.00 % |
52 Week High | $63.11 |
52 Week Low | $43.31 |
Volume | 0 |
Shares Issued | 2,006.00m |
Beta | 0.34 |
RiskGrade | 106 |
Strong Buy | 3 |
Buy | 3 |
Neutral | 19 |
Sell | 2 |
Strong Sell | 0 |
Total | 27 |
Time | Volume / Share Price |
15:50 | 100 @ $45.50 |
15:50 | 100 @ $45.51 |
15:50 | 100 @ $45.50 |
15:50 | 100 @ $45.52 |
15:50 | 400 @ $45.52 |
You are here: research